Gordon BBE, et al. - Given that less aggressive treatment received by African American (AA) patients vs white patients likely contributes to prostate cancer racial disparities in mortality outcomes, researchers focused on the reasons underlying the disparities in treatment by examining a prospective, population-based cohort comprising 1170 men with newly diagnosed nonmetastatic prostate cancer. By 78% to 80% of AA and white patients with low-risk cancer, their cancers were “not very aggressive.” However, 54% of AA patients with high-risk perceived their cancers to be “not very aggressive,” whereas 24% of white patients with high-risk did. Findings revealed perceived cancer aggressiveness and cure as the most significant factor were significantly related to receiving any aggressive treatment and were related to surgery (vs radiation), in a multivariable analysis. No significant association of race with the treatment received was evident following adjustments for these factors and sociodemographic factors.